| Ticker Details |
|
Vivos Therapeutics, Inc.
|
| IPO Date: |
July 7, 2020 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$5.98M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.20 | 6.02%
|
| Avg Daily Range (30 D): |
$0.02 | 5.53%
|
| Avg Daily Range (90 D): |
$0.04 | 6.22%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1M |
| Avg Daily Volume (30 D): |
1.86M |
| Avg Daily Volume (90 D): |
1.71M |
| Trade Size |
| Avg Trade Size (Sh.): |
289 |
| Avg Trade Size (Sh.) (30 D): |
462 |
| Avg Trade Size (Sh.) (90 D): |
416 |
| Institutional Trades |
| Total Institutional Trades: |
25 |
| Avg Institutional Trade: |
$.96M |
| Avg Institutional Trade (30 D): |
$.65M |
| Avg Institutional Trade (90 D): |
$.65M |
| Avg Institutional Trade Volume: |
.03M |
| Avg Institutional Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.05M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$.84M |
| Avg Closing Volume: |
12.46K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-1.9
|
$-.31
|
$-.52
|
|
Diluted EPS
|
$-1.9
|
$-.31
|
$-.52
|
|
Revenue
|
$20.9M
|
$5.15M
|
$5.14M
|
|
Gross Profit
|
$12.94M
|
$2.95M
|
$3.06M
|
|
Net Income / Loss
|
$-25.63M
|
$-5.52M
|
$-7.75M
|
|
Operating Income / Loss
|
$-22.56M
|
$-4.83M
|
$-6.62M
|
|
Cost of Revenue
|
$7.96M
|
$2.2M
|
$2.08M
|
|
Net Cash Flow
|
$-2.63M
|
$-.26M
|
$M
|
|
PE Ratio
|
|
|
|
|
|
|